22h
Hosted on MSNGLP-1 Drugs and Colonoscopy; GI Symptoms Post-COVID; Identifying High-Risk Barrett'sA systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...
The results paint a stark picture of the financial challenges faced by individuals living with inflammatory bowel disease (IBD) in the United States. Our survey, which included responses from more ...
Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets for high-quality clinical trials have been recognised as robust and ...
15d
GlobalData on MSNICR scientists develop algorithm that predicts bowel cancer risk in IBD patientsWith types that include ulcerative colitis and Crohn's disease, IBD can cause pre-cancerous cells if the bowel lining remains inflamed and untreated. ICR London Centre for Evoluti ...
Suspected CD with negative findings on upper GI endoscopy and colonoscopy; Evaluation of obscure (gastroscopy- and colonoscopy-negative) GI bleeding in patients with CD; Evaluation of disease ...
Baseline histologic activity predicted colectomy risk in ulcerative colitis treated with biologics, independent of clinical or endoscopic factors.
“We are interested in how these microbiome changes influence the course of disease in patients with chronic inflammatory bowel disease (IBD),” explained Professor Philip Rosenstiel, member of ...
Patients were followed according to the Mayo Endoscopic Score (0 vs 1 and ... predictive markers is one major focus area in inflammatory bowel disease. Mucosal healing (MH) has emerged as a ...
33,530 people played the daily Crossword recently. Can you solve it faster than others?33,530 people played the daily Crossword recently. Can you solve it faster than others? Larry Ellison, Oracle ...
Please provide your email address to receive an email when new articles are posted on . Celiac patients had higher risks for pancreatic, esophageal, colonic and gastric cancers but not rectal ...
Mount Sinai researchers demonstrate how wearable technology and artificial intelligence revolutionize inflammatory bowel disease management, offering unprecedented early detection and personalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results